Jinshi Data News on July 30th, the Shenzhen Stock Exchange issued a decision to terminate the review of the initial public issuance of Wanguo Pharmaceutical and its listing on the Growth Enterprise Market.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Shenzhen Stock Exchange: Terminate the first public issuance of Wanguo Pharmaceutical and review its listing on the ChiNext board
Jinshi Data News on July 30th, the Shenzhen Stock Exchange issued a decision to terminate the review of the initial public issuance of Wanguo Pharmaceutical and its listing on the Growth Enterprise Market.